Boehringer Ingelheim, Cue Biopharma partner to develop next─generation treatment for autoimmune and inflammatory ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, and Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, announced a strategic research collaboration and license agreement to develop and commercialize …